AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 6 added, 2 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $94.78
- 52-wk high
- $99.16
- High
- $95.79
- 52-wk low
- $66.79
- Low
- $94.72
- Prev close
- $96.47
- Mkt cap
- $271.23B
- P/E
- 10.5x
- Volume
- 7.48M
- Fwd P/E
- 9.6x
- Beta
- -0.22
- Div yield
- 1.57%
- P/S
- 0.9x
- P/B
- 1.5x
- Profit margin
- +8.8%
- Op margin
- +16.7%
- ROE
- +14.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about SHEL filings
Are insiders buying or selling Shell PLC ADR (SHEL) stock?
Neither. Shell PLC ADR (SHEL) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded SHEL recently?
None. No member of Congress disclosed a SHEL trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this SHEL smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (2)
- CI
Citadel
$90.8M
added
- BR
Bridgewater
$89.3M
added
Sells/Trims (1)
- QR
Qube Research
$75.3M
sold
How top traders are positioned
No tracked top-trader positions in SHEL right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 9.0% above what analysts expected.
Earnings per share
$3.23 expected
Reports Oct 29, 2026, in 28 days
Estimates as of Sep 30, 2026
EPS expected
$2.78 to $4.07
Revenue expected
1 analysts
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $68.15B | $64.00B | $69.69B | $94.66B |
| Cost of what it sold | $56.58B | $54.00B | $56.26B | $76.19B |
| Gross profit | $11.58B | $10.00B | $13.43B | $18.48B |
| What it spent | ||||
| Research and development | $409.0M | $297.6M | $167.0M | $277.0M |
| Sales and admin | $3.26B | $3.43B | $2.80B | $2.91B |
| Other operating costs | $175.0M | -$125.8M | $98.0M | $110.0M |
| Total operating expenses | $3.84B | $3.60B | $3.07B | $3.30B |
| What was left | ||||
| Operating profit | $7.73B | $12.13B | $10.37B | $15.18B |
| Interest on debt | $1.28B | $1.19B | $1.47B | $1.11B |
| Profit before tax | $7.92B | $6.89B | $9.33B | $15.75B |
| Tax | $2.50B | $2.71B | $3.57B | $4.95B |
| Net profit | $5.32B | $4.13B | $5.69B | $10.82B |
| EBITDA | $15.03B | $12.13B | $16.54B | $22.43B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace